We are working on upgrading our websites and despite our best endeavours have experienced census type calamities for almost a week now. Our apologies, we hope to have all problems resolved by Monday August 15th.

InvestoGain Australia



Browse Australian listed companies0-9A BC DE FGH IJ KL MN OP QR ST UV WX YZ
Browse current Australian managed funds0-9A BCDE FGH IJKL MNOP QRST UVWX YZ


Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:


Former Name ASX


Former (or subsequent) names

MOZAMBI RESOURCES LTD16/12/201401/04/2016
MOZAMBI COAL LIMITED25/02/201116/12/2014
RTL CORPORATION LIMITED23/05/200825/02/2011

Shareholder links



Advanced Share Registry Services, 110 Stirling Hwy, Nedlands WA 6009

Tel : +61 8 9389 8033
Fax : +61 8 9262 3723
RegistryWebsite RegistryEmail

Company details

Address: Level 17 , 201 Miller Street , NORTH SYDNEY , NSW, AUSTRALIA, 2060
Tel:  02 8923 2512 Fax: 02 8923 2525

Date first listed: 19/12/2003
Company Secretary: Mr Guy Robertson
Sector: Health Care Equipment & Services Industry Group: XHJ
Activities: Medical technology company offering products and technologies dor safety injection solutions
name changed to RTL Corporation Limited23/05/2008
securities reinstated to quotation19/05/2008
the Company has now satisfied all pre-conditions to seeking reinstatement to trading of its securities on the Australian Securities Exchange and will be reinstated to quotation on Monday 19 May16/05/2008
we understand that on or about this date the company consolidated its shares 1 for 217/04/2008
all resolutions were carried at the Company's General Meeting today16/04/2008
capital of the company is being consolidated one share for every two held16/04/2008
releases a placement prospectus25/03/2008
releases half yearly accounts29/02/2008
directors advise the market of certain material events that have allegedly resulted in the Company incurring substantial debts that the Directors were not previously aware of - as a result of these debts being brought to the attention of the Company, the Directors have limited options available to them to ensure that the Company remains a going concern22/02/2008
a cash flow report for the quarter to 31 December 2007 shows a deficit at operating level of $70k and cash on hand of -$1k31/01/2008
the company has recently begun discussions with another British company regarding the rights to the syringe technology - the company has several options for recapitalizing and moving forward, however these options are still in the process of being evaluated25/01/2008
both resolutions at today's AGM were passed30/11/2007
a cash flow report for the quarter to 30 September 2007 shows a deficit at operating level of $18k and cash on hand of $30k01/11/2007
company provides notice of an Annual General Meeting to be held on Thursday 29 November 2007, at 11am (EST) at Level 12, 459 Collins Street, Melbourne, Victoria30/10/2007
company releases its Preliminary Final Report31/08/2007
company says its restructuring plan has been completed and overheads reduced to a minimum - the ASX trading halt on Ritract shares will stay in place until such time as the company has solid news to announce regarding three licensing deals28/08/2007
a cash flow report for the quarter to 30 June 2007 shows a deficit at operating level of $146k and cash on hand of $48k31/07/2007
after a restructuring, the company has only one employee, Mr Tom Davenport, who has been appointed Chief Executive Officer of the company (previously Head of Research and Development and Engineering) - the company is continuing discussions with companies who have expressed an interest in licensing the company's technology and/or have an interest in investing in the company30/07/2007
MD Bill Nicklin and non-exec director Tony Fitzgerald resign29/06/2007
securities suspended from quotation whilst a restructure is implemented26/06/2007
shares reinstated to quotation08/11/2006
company advises that pre market release testing found that a small percentage of products failed to operate correctly and under the rules of the QMS it is unable to release product - this had implications for the Company's ongoing funding requirements and in particular for the completion of its announced capital raising - it also prevented the completion and lodgement of Ritract's 2006 Annual Report - the Board has made the decision not to invest further funds into development of the Needlesleeve technology - the board expects the minor production issues to be overcome shortly16/10/2006
securities suspended from quotation because of failure to lodge full year accounts for the period to 30 June 200602/10/2006

ASX Announcements (courtesy of ASX)


Your comments

Please read our Terms before viewing comments.


Company Updates

Post your comments here

Please read our Terms before posting comments.
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    Posting your comments. Please wait...

    Directors' on-market share transactions (last 5)


    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    Robert HemphillDirector
    Alex NeulingDirector16/04/2008
    Ashley PattisonDirector

    Date of first appointment, title may have changed.

    Directors & Executives (former)


    Date of first appointment, title may have changed.